21 CFR 882.5889 — Electrical Tongue Stimulator To Treat Motor Deficits
Neurology (NE) · Part 882 Subpart F—Neurological Therapeutic Devices · § 882.5889
Identification
An electrical tongue nerve stimulator to treat motor deficits is a prescription device that consists of a non-implantable apparatus to generate electrical pulses for stimulation of the nerves in the tongue to provide treatment of motor deficits.
Classification Rationale
Class II (special controls). The special controls for this device are:
Product Codes
| Product Code | Device Name | Class | Devices | Attributes |
|---|---|---|---|---|
| QCF | Electrical Tongue Stimulator To Treat Motor Deficits | 2 | 1 | SaMD |
Special Controls
QCF — Electrical Tongue Stimulator To Treat Motor Deficits
In combination with the general controls of the FD&C Act, the electrical tongue nerve stimulator to treat motor deficits is subject to the following special controls:
De Novo Order DEN200050
QCF — Electrical Tongue Stimulator To Treat Motor Deficits
*Classification.* Class II (special controls). The special controls for this device are:(1) Performance data must demonstrate that all patient-contacting components of the device are biocompatible. (2) Performance data must demonstrate the electromagnetic compatibility, battery safety, and electrical, mechanical, and thermal safety of the device. (3) Non-clinical performance testing must characterize the electrical stimulation parameters of the device. (4) Software verification, validation, and hazard analysis must be performed. Software documentation must include an assessment of the impact of threats and vulnerabilities on device functionality and end users as part of cybersecurity review. (5) Labeling must include: (i) A detailed summary of the device's technical parameters; (ii) Instructions for use; (iii) Cleaning, storage, and charging instructions; and (iv) Disposal instructions.
eCFR
QCF — Electrical Tongue Stimulator To Treat Motor Deficits
(1) Performance data must demonstrate that all patient-contacting components of the device are biocompatible. (2) Performance data must demonstrate the electromagnetic compatibility, battery safety, and electrical, mechanical, and thermal safety of the device. (3) Non-clinical performance testing must characterize the electrical stimulation parameters of the device. (4) Software verification, validation, and hazard analysis must be performed. Software documentation must include an assessment of the impact of threats and vulnerabilities on device functionality and end users as part of cybersecurity review. (5) Labeling must include: (i) A detailed summary of the device's technical parameters; (ii) Instructions for use; (iii) Cleaning, storage, and charging instructions; and (iv) Disposal instructions.
Ecfr Llm
